In the first of a new article series, we talk with Ola Gudmundsen, CEO LINK Medical, about being part of Oslo Cancer Cluster during the past 13 years.
LINK Medical is a full-service contract research organization (CRO) – but like most other companies, it did not start that way. When the company joined Oslo Cancer Cluster in 2008, it was a medium-sized CRO.
During the past 13 years as a member, LINK has developed many collaborations with other member companies and participated in a variety of events.
An incredible journey
“It has been an incredible journey. We have developed as a company through conferences and lectures, as well as through the work we have done for other companies. Supporting Oslo Cancer Cluster’s work and being part of the cluster community enables us to contribute to the fight against cancer,” said Ola Gudmundsen, CEO LINK Medical.
The company provides product development services for the pharmaceutical and medical device industries across Northern Europe. According to the home page, the company regards itself “a pragmatic problem-solver” all the way from early drug development to European and American clinical studies within cancer.
“We are now working with advanced therapies and can therefore contribute in important areas where future cancer treatments are being developed,” said Gudmundsen.
Three aspects of value
“The value of the membership lies in three aspects: the events, the collaborations, and the community,” said Gudmundsen, and continued:
“The events are arenas for learning and understanding what is happening in the field of cancer research. Also, the events help us to know the Norwegian cancer research environment through presentations from other members. The collaborations and conversations within the cluster are important because they often are about ideas that can be developed into cancer treatments. The community has a common goal to fight cancer.”
The company has collaborated with many of the other cluster members throughout the years, and lately, they have also developed collaborations with foreign companies.
“Companies we work with can benefit from our expertise, to supplement their own experts and have good discussions about developmental strategies,” said Gudmundsen.
LINK Medical specialises in a whole range of areas within cancer as well as over 20 other therapeutic areas. Read more about these areas on the LINK Medical web page: https://linkmedical.eu/
In a new article series, called Cluster Collaborations, we present members who have a cluster story to tell. We want to highlight the fruitful collaborations in the cluster, underlining the very essence of what Oslo Cancer Cluster is all about, from cancer research to cure.